254 related articles for article (PubMed ID: 29070758)
1. Metabolic Considerations in Atrial Fibrillation - Mechanistic Insights and Therapeutic Opportunities.
Harada M; Melka J; Sobue Y; Nattel S
Circ J; 2017 Nov; 81(12):1749-1757. PubMed ID: 29070758
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive metabolomic and proteomic analyses reveal candidate biomarkers and related metabolic networks in atrial fibrillation.
Zhou J; Sun L; Chen L; Liu S; Zhong L; Cui M
Metabolomics; 2019 Jun; 15(7):96. PubMed ID: 31227919
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression.
Heijman J; Voigt N; Nattel S; Dobrev D
Circ Res; 2014 Apr; 114(9):1483-99. PubMed ID: 24763466
[TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation pathophysiology: implications for management.
Iwasaki YK; Nishida K; Kato T; Nattel S
Circulation; 2011 Nov; 124(20):2264-74. PubMed ID: 22083148
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs and atrial fibrillation: mechanisms and translational potential.
Luo X; Yang B; Nattel S
Nat Rev Cardiol; 2015 Feb; 12(2):80-90. PubMed ID: 25421165
[TBL] [Abstract][Full Text] [Related]
6. Atrial metabolism and tissue perfusion as determinants of electrical and structural remodelling in atrial fibrillation.
Opacic D; van Bragt KA; Nasrallah HM; Schotten U; Verheule S
Cardiovasc Res; 2016 Apr; 109(4):527-41. PubMed ID: 26786160
[TBL] [Abstract][Full Text] [Related]
7. Remodeling of myocardial energy and metabolic homeostasis in a sheep model of persistent atrial fibrillation.
Jie QQ; Li G; Duan JB; Li XB; Yang W; Chu YP; Yu SD; Liu XY; Wang CY; Liu FF; Ze F; Huang YW; Chen Y; Ding YS; Guo JH; Wu L
Biochem Biophys Res Commun; 2019 Sep; 517(1):8-14. PubMed ID: 31307785
[TBL] [Abstract][Full Text] [Related]
8. Combined metabolomic and proteomic analysis of human atrial fibrillation.
Mayr M; Yusuf S; Weir G; Chung YL; Mayr U; Yin X; Ladroue C; Madhu B; Roberts N; De Souza A; Fredericks S; Stubbs M; Griffiths JR; Jahangiri M; Xu Q; Camm AJ
J Am Coll Cardiol; 2008 Feb; 51(5):585-94. PubMed ID: 18237690
[TBL] [Abstract][Full Text] [Related]
9. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives.
Nattel S; Harada M
J Am Coll Cardiol; 2014 Jun; 63(22):2335-45. PubMed ID: 24613319
[TBL] [Abstract][Full Text] [Related]
10. Alterations of atrial Ca(2+) handling as cause and consequence of atrial fibrillation.
Greiser M; Lederer WJ; Schotten U
Cardiovasc Res; 2011 Mar; 89(4):722-33. PubMed ID: 21159669
[TBL] [Abstract][Full Text] [Related]
11. Redox control of cardiac remodeling in atrial fibrillation.
Wolke C; Bukowska A; Goette A; Lendeckel U
Biochim Biophys Acta; 2015 Aug; 1850(8):1555-65. PubMed ID: 25513966
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in Atrial Fibrillation: from Expression Signatures to Functional Implications.
van den Berg NWE; Kawasaki M; Berger WR; Neefs J; Meulendijks E; Tijsen AJ; de Groot JR
Cardiovasc Drugs Ther; 2017 Jun; 31(3):345-365. PubMed ID: 28752208
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Inflexibility as a Pathogenic Basis for Atrial Fibrillation.
Qin X; Zhang Y; Zheng Q
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955426
[TBL] [Abstract][Full Text] [Related]
14. Atrial fibrillation: recent advances in understanding the role of microRNAs in atrial remodeling with an electrophysiological overview.
Poudel P; Xu Y; Cui Z; Sharma D; Tian B; Paudel S
Cardiology; 2015; 131(1):58-67. PubMed ID: 25871909
[TBL] [Abstract][Full Text] [Related]
15. Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective.
Nattel S; Heijman J; Zhou L; Dobrev D
Circ Res; 2020 Jun; 127(1):51-72. PubMed ID: 32717172
[TBL] [Abstract][Full Text] [Related]
16. [Biology of the substrate of atrial fibrillation].
Hatem S
Biol Aujourdhui; 2012; 206(1):5-9. PubMed ID: 22463991
[TBL] [Abstract][Full Text] [Related]
17. New biomarkers from multiomics approaches: improving risk prediction of atrial fibrillation.
Kornej J; Hanger VA; Trinquart L; Ko D; Preis SR; Benjamin EJ; Lin H
Cardiovasc Res; 2021 Jun; 117(7):1632-1644. PubMed ID: 33751041
[TBL] [Abstract][Full Text] [Related]
18. Cardiomyocyte Remodeling in Atrial Fibrillation and Hibernating Myocardium: Shared Pathophysiologic Traits Identify Novel Treatment Strategies?
Weil BR; Ozcan C
Biomed Res Int; 2015; 2015():587361. PubMed ID: 26221599
[TBL] [Abstract][Full Text] [Related]
19. The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis.
Heijman J; Algalarrondo V; Voigt N; Melka J; Wehrens XH; Dobrev D; Nattel S
Cardiovasc Res; 2016 Apr; 109(4):467-79. PubMed ID: 26705366
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria and the Pathophysiological Mechanism of Atrial Fibrillation.
Li X; Yang X; Li Y; Yuan M; Tian C; Yang Y; Zhang X; Liu C; Gao Y; Liu N; Shang H; Xing Y
Curr Pharm Des; 2018; 24(26):3055-3061. PubMed ID: 30179127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
